NCT03717571

Brief Summary

Degenerative partial and complete rupture of the rotator cuff is a common injury among elder patients. However, the clinical manifestation varies largely with some patients having severe pain and limiting range of motion and others having no complaints. The basic functions of the rotator cuff are to facilitate shoulder motion and stabilization and centering of the glenohumeral joint. The objective of this study is to quantify the difference in superior glenohumeral translation in patients with degenerative rotator cuff tear compared to healthy control subjects and to determine the effect of isolated complete supraspinatus tear and combined complete supraspinatus and either partial infraspinatus or partial subscapularis tear.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2018

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

October 22, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 24, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2019

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

March 3, 2022

Status Verified

March 1, 2022

Enrollment Period

5 months

First QC Date

October 22, 2018

Last Update Submit

March 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glenohumeral translation

    Amount of glenohumeral translation under load

    Baseline

Secondary Outcomes (6)

  • Disabilities of arm, shoulder and Hand (DASH)

    Baseline

  • Shoulder function

    Baseline

  • Shoulder pain

    Baseline

  • Critical shoulder angle (CSA)

    Baseline

  • Muscle activity

    Baseline

  • +1 more secondary outcomes

Study Arms (3)

Control group

age and sex matched healthy control persons

Diagnostic Test: Glenohumeral translation assessment

isolated tear

patients with isolated complete supraspinatus muscle tear

Diagnostic Test: Glenohumeral translation assessment

combined tear

patients with complete supraspinatus muscle tear and either partial infraspinatus muscle tear or partial subscapularis muscle tear

Diagnostic Test: Glenohumeral translation assessment

Interventions

amount of glenohumeral translation under load

Control groupcombined tearisolated tear

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* 10 patients with isolated complete supraspinatus muscle tear * 10 patients with complete supraspinatus muscle tear and either partial infraspinatus muscle tear or partial subscapularis muscle tear * 10 healthy control subjects

You may qualify if:

  • years ≤ age ≤ 65 years
  • Degenerative complete supraspinatus muscle tear or complete supraspinatus muscle tear and either partial infraspinatus muscle tear or partial subscapularis muscle tear
  • Unilateral rotator cuff tear

You may not qualify if:

  • Traumatic tendon ruptures
  • Incomplete supraspinatus muscle tear
  • Tears in more than two rotator cuff muscles
  • Prior conservative treatment or surgery of the ipsilateral upper extremity
  • Clinical history of the contralateral glenohumeral joint
  • Range of motion \< 90° in abduction and flexion
  • Neuromuscular disorders affecting upper limb movement
  • Additional pathologies that influence the mobility of the shoulder joints
  • Inability to provide informed consent
  • 45 years ≤ age ≤ 65 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Basel

Basel, Canton of Basel-City, 4031, Switzerland

Location

MeSH Terms

Conditions

Rotator Cuff InjuriesRupture

Condition Hierarchy (Ancestors)

Wounds and InjuriesShoulder InjuriesTendon Injuries

Study Officials

  • Annegret Mündermann, PhD

    University Hospital, Basel, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2018

First Posted

October 24, 2018

Study Start

October 4, 2018

Primary Completion

February 22, 2019

Study Completion

September 30, 2020

Last Updated

March 3, 2022

Record last verified: 2022-03

Locations